HomeCompareSHWGF vs GBDC

SHWGF vs GBDC: Dividend Comparison 2026

SHWGF yields 3.85% · GBDC yields 11.85%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 GBDC wins by $20.66M in total portfolio value
10 years
SHWGF
SHWGF
● Live price
3.85%
Share price
$0.52
Annual div
$0.02
5Y div CAGR
38.1%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$116.0K
Annual income
$38,332.89
Full SHWGF calculator →
GBDC
GBDC
● Live price
11.85%
Share price
$12.66
Annual div
$1.50
5Y div CAGR
51.1%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$20.78M
Annual income
$16,389,263.41
Full GBDC calculator →

Portfolio growth — SHWGF vs GBDC

📍 GBDC pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodSHWGFGBDC
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, SHWGF + GBDC cover 0 of 12 monthsgood coverage

Jan
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec
SHWGF pays
GBDC pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

SHWGF
Annual income on $10K today (after 15% tax)
$326.92/yr
After 10yr DRIP, annual income (after tax)
$32,582.96/yr
GBDC
Annual income on $10K today (after 15% tax)
$1,007.11/yr
After 10yr DRIP, annual income (after tax)
$13,930,873.90/yr
At 15% tax rate, GBDC beats the other by $13,898,290.94/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of SHWGF + GBDC for your $10,000?

SHWGF: 50%GBDC: 50%
100% GBDC50/50100% SHWGF
Portfolio after 10yr
$10.45M
Annual income
$8,213,798.15/yr
Blended yield
78.63%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on GBDC right now

SHWGF
No analyst data
Altman Z
2.6
Piotroski
6/9
GBDC
Analyst Ratings
6
Buy
5
Hold
Consensus: Buy
Price Target
$14.00
+10.6% upside vs current
Range: $13.00 — $15.00
Altman Z
0.6
Piotroski
6/9
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

SHWGF buys
0
GBDC buys
0
No recent congressional trades found for SHWGF or GBDC in the last 90 days.
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricSHWGFGBDC
Forward yield3.85%11.85%
Annual dividend / share$0.02$1.50
Payout ratio50%50%
1-year div growth0%0%
5-year div CAGR38.1%51.1%
Portfolio after 10y$116.0K$20.78M
Annual income after 10y$38,332.89$16,389,263.41
Total dividends collected$87.0K$20.36M
Payment frequencyquarterlyquarterly
SectorStockBDC

Year-by-year: SHWGF vs GBDC ($10,000, DRIP)

YearSHWGF PortfolioSHWGF Income/yrGBDC PortfolioGBDC Income/yrGap
1← crossover$11,231$531.15$12,490$1,790.28$1.3KGBDC
2$12,787$769.94$16,522$3,157.73$3.7KGBDC
3$14,814$1,131.40$23,578$5,898.68$8.8KGBDC
4$17,542$1,691.67$37,115$11,886.75$19.6KGBDC
5$21,356$2,585.53$66,136$26,423.57$44.8KGBDC
6$26,913$4,062.45$137,257$66,491.44$110.3KGBDC
7$35,405$6,607.64$341,734$194,868.54$306.3KGBDC
8$49,102$11,218.96$1,050,788$685,133.02$1.00MGBDC
9$72,621$20,081.68$4,099,314$2,974,971.01$4.03MGBDC
10$116,037$38,332.89$20,775,530$16,389,263.41$20.66MGBDC

SHWGF vs GBDC: Complete Analysis 2026

SHWGFStock

Shandong Weigao Group Medical Polymer Company Limited engages in the research and development, production, and sale of single-use medical devices in the People's Republic of China. It operates through Medical Device Products, Orthopaedic Products, Interventional Products, Pharma Packaging Products, Blood Management Products, and Others segments. The company offers vascular and non-vascular access infusion devices, infusion sets, syringes, puncture needles, and specialized single-use clinical collection kits; wound sutures, wound healing dressings, and wound cleaning and nonvascular catheter supporting extracorporeal devices; and blood collection, storage, separation, and sterilization equipment. It also provides prefilled syringes and pre-filled flush syringes; blood collection and blood glucose testing devices; and general anesthesia consumables, local anesthesia consumables, anesthesia auxiliary consumables, ICU equipment, and open and minimally invasive surgical equipment. In addition, the company engages in the production and sale of orthopedic devices; tumor and blood vessel interventional instruments; implantation materials and artificial organs; medical PVC granules, plastic packing bags, and carton boxes; industrial automatic equipment and parts; molds; hemodialysis equipment; and type I, type II, and type III medical devices. Further, it is involved in the finance leasing and factoring business; wholesale of type I medical devices, surgical devices, and other disposal medical products; provision of asset management, enterprise consulting, enterprise management advisory services, as well as logistics and storage services, as well as export its products. The company offers its products under the Jierui, Wego Ortho, Yahua, Bangde, and Hai Xing brands. It serves hospitals, blood stations, and other medical units; and distributors. The company was incorporated in 2000 and is based in Weihai, the People's Republic of China.

Full SHWGF Calculator →

GBDCBDC

Golub Capital BDC, Inc. (GBDC) is a business development company and operates as an externally managed closed-end non-diversified management investment company. It invests in debt and minority equity investments in middle-market companies that are, in most cases, sponsored by private equity investors. It typically invests in diversified consumer services, automobiles, healthcare technology, insurance, health care equipment and supplies, hotels, restaurants and leisure, healthcare providers and services, IT services and specialty retails. It seeks to invest in the United States. It primarily invests in first lien traditional senior debt, first lien one stop, junior debt and equity, senior secured, one stop, unitranche, second lien, subordinated and mezzanine loans of middle-market companies, and warrants.

Full GBDC Calculator →
📬

Get this SHWGF vs GBDC comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

SHWGF vs SCHDSHWGF vs JEPISHWGF vs OSHWGF vs KOSHWGF vs MAIN

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.